Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

October 2016 - FRMC

Featured Article

House of Cards: How Much Longer Can the ACA Hold Up?
10/20/2016
With insurers pulling out, premiums on the rise, and the presidential election on the way, the fate of Obamacare hangs in the balance. 
With insurers pulling out, premiums on the rise, and the presidential election on the way, the fate of Obamacare hangs in the balance. 
With insurers pulling out,...
10/20/2016
First Report Managed Care

Department

News Connection
Payment Fears Drive Americans to Delay Emergency Care
10/20/2016
Approximately 1 in 4 Americans reported worsened medical conditions after postponing an ED visit due to cost and insurance coverage concerns.
Approximately 1 in 4 Americans reported worsened medical conditions after postponing an ED visit due to cost and insurance coverage concerns.
Approximately 1 in 4 Americans...
10/20/2016
First Report Managed Care
News Connection
Anthem Refuses To Cover Exondys 51 Citing Lack of Efficacy Evidence
10/20/2016
The largest US health insurer, Anthem Inc, recently announced it would not cover the first FDA-approved Duchenne muscular dystrophy drug (DMD), Exondys 51 (eteplirsen; Sarepta Therapeutics) due to concerns over clinical trial data.
The largest US health insurer, Anthem Inc, recently announced it would not cover the first FDA-approved Duchenne muscular dystrophy drug (DMD), Exondys 51 (eteplirsen; Sarepta Therapeutics) due to concerns over clinical trial data.
The largest US health insurer,...
10/20/2016
First Report Managed Care
News Connection
Random, Inconsistent Price Hikes Hitting Hospitals Hard
10/20/2016
Inpatient drug costs rose 38.7% per admission between 2013 and 2015, according to a new analysis from the National Opinion Research Center at the University of Chicago.
Inpatient drug costs rose 38.7% per admission between 2013 and 2015, according to a new analysis from the National Opinion Research Center at the University of Chicago.
Inpatient drug costs rose 38.7%...
10/20/2016
First Report Managed Care
News Connection
Statewide Programs Should Track All Prescriptions, Not Just Opiates
10/20/2016
A recent commentary in The American Journal of Managed Care suggests that policymakers should expand prescription drug monitoring programs to include all medications instead of opiates alone to help reduce outpatient medication errors.
A recent commentary in The American Journal of Managed Care suggests that policymakers should expand prescription drug monitoring programs to include all medications instead of opiates alone to help reduce outpatient medication errors.
A recent commentary in The...
10/20/2016
First Report Managed Care
News Connection
Payer Pressure on MBHOs Can Improve Psychiatric Care
10/20/2016
According to a recent editorial, pressure from a patient or payer often rectifies situations where managed behavioral health care organizations are providing poor psychiatric treatment.
According to a recent editorial, pressure from a patient or payer often rectifies situations where managed behavioral health care organizations are providing poor psychiatric treatment.
According to a recent editorial,...
10/20/2016
First Report Managed Care
Trends Report
Autoimmune Diseases: Psoriasis and Atopic Dermatitis
10/20/2016
This will serve as part 2 of the 3-part First Report Managed Care Trends Report on autoimmune diseases. This second part will report the findings from survey participants on psoriasis and atopic dermatitis.
This will serve as part 2 of the 3-part First Report Managed Care Trends Report on autoimmune diseases. This second part will report the findings from survey participants on psoriasis and atopic dermatitis.
This will serve as part 2 of the...
10/20/2016
First Report Managed Care
Formulary Frontlines®
Asthma Therapy: Understanding the Factors Contributing to the Cost Burden
10/20/2016
According to the CDC, asthma affects approximately 26 million Americans at an incremental cost of $56 billion annually; while Medicaid spends over $10 billion per year treating asthma. Severe asthma caused by poor medication adherence leads...
According to the CDC, asthma affects approximately 26 million Americans at an incremental cost of $56 billion annually; while Medicaid spends over $10 billion per year treating asthma. Severe asthma caused by poor medication adherence leads...
According to the CDC, asthma...
10/20/2016
First Report Managed Care
Department
Better Coverage Needed for Increasing Trend of Genetic Testing Utilization
10/20/2016
An increase in genetic testing expenditures in specialty pharmacy requires improved coverage as utilization and expenditures are expected to grow in the coming years, according to recent research at the 2016 NASP Annual Meeting.
An increase in genetic testing expenditures in specialty pharmacy requires improved coverage as utilization and expenditures are expected to grow in the coming years, according to recent research at the 2016 NASP Annual Meeting.
An increase in genetic testing...
10/20/2016
First Report Managed Care
Department
Patient Assistance, Copay Assistance Increase Access to Specialty Pharmacy Drugs
10/20/2016
Implementation of patient assistance programs and copay assistance programs increased access to specialty medications.
Implementation of patient assistance programs and copay assistance programs increased access to specialty medications.
Implementation of patient...
10/20/2016
First Report Managed Care
Department
“Smart Pill-Bottle” Significantly Improves Medication Adherence
10/20/2016
Research showed that use of a “smart pill-bottle,” which provides additional reminders and instructions to patients, increased medication adherence.
Research showed that use of a “smart pill-bottle,” which provides additional reminders and instructions to patients, increased medication adherence.
Research showed that use of a...
10/20/2016
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
AbbVie Files Patent Suit Over Humira Biosimilar
08/09/2016
AbbVie Inc has filed a patent infringement lawsuit against Amgen Inc, claiming that its biosimilar copy for top-selling Humira breaches 10 patents despite the FDA panel’s recommendation for approval.
AbbVie Inc has filed a patent infringement lawsuit against Amgen Inc, claiming that its biosimilar copy for top-selling Humira breaches 10 patents despite the FDA panel’s recommendation for approval.
AbbVie Inc has filed a patent...
08/09/2016
First Report Managed Care
News
Digital Inhaler Associated With Heightened Odds of Improvement in Asthma Control
09/23/2022
“This study highlights the potential of a digital health tool to support asthma management and physician-patient interactions and discussions around inhaler technique and adherence," researchers said.
“This study highlights the potential of a digital health tool to support asthma management and physician-patient interactions and discussions around inhaler technique and adherence," researchers said.
“This study highlights the...
09/23/2022
First Report Managed Care
Subcutaneous versus Intravenous Abatacept in Rheumatoid Arthritis
02/22/2012
Chicago—The efficacy and safety of subcutaneous (SC) abatacept to treat rheumatoid arthritis (RA) was maintained over 24 months, according to investigators of a recent open-label long-term extension study that looked at 24-month follow-up...
Chicago—The efficacy and safety of subcutaneous (SC) abatacept to treat rheumatoid arthritis (RA) was maintained over 24 months, according to investigators of a recent open-label long-term extension study that looked at 24-month follow-up...
Chicago—The efficacy and safety...
02/22/2012
First Report Managed Care
News
Brief Federal Shutdown Wouldn`t Faze Medicare Or Medicaid
04/08/2011
04/08/2011
First Report Managed Care
News
FibroGen wins `orphan` designation for lung disease drug
08/01/2012
08/01/2012
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

October 2016 Volume 13 Issue 10

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement